ArticleIranian journal of pharmaceutical research : IJPR2016
The Impact of the Sanctions Made Against Iran on Availability to Asthma Medicines in Tehran.
Article in Iranian journal of pharmaceutical research : IJPR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Direct and indirect effects of economic sanctions on health: a systematic narrative literature review.BMC public health · 2024Pooled it
- The impact of economic sanctions on health and health systems in low-income and middle-income countries: a systematic review and narrative synthesis.BMJ global health · 2023Pooled it
- The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.The Lancet. Global health · 2022Pooled it
- Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.International journal of health policy and management · 2018Pooled it
- Health service disruptions under economic sanctions: evidence from Iran.International journal for equity in health · 2026Article
- [Effect of economic sanctions on the quality of hospital management of severe acute malnutrition in Niger: a multicenter retrospective study].The Pan African medical journal · 2026Article
- Dispensing of medicines for asthma and chronic obstructive pulmonary disease through the government health insurance in Syria: a retrospective analysis.Global health action · 2025Article
- The Impact of Economic Sanctions on Health and Strategies for Mitigation: A Glance at the Case of Iran.International journal of preventive medicine · 2025Review
- The experiences and perceptions of people with chronic and rare diseases during political-economic sanctions in Iran: a qualitative study.BMC health services research · 2024Article
- Economic barriers and gaps to reach the desirable consumption of salt, sugar, and fat in Iran: a qualitative study.Journal of health, population, and nutrition · 2023Article
- Out-of-pocket payments for treatment of COVID-19 in Iran.Cost effectiveness and resource allocation : C/E · 2022Article
- Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.Iranian journal of medical sciences · 2022Article
- Attributes Development for Pharmaceutical Subsidization: A Qualitative Study.Iranian journal of pharmaceutical research : IJPR · 2020Article
- Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019Article
- Impact of United States political sanctions on international collaborations and research in Iran.BMJ global health · 2019Review
- Economic Sanctions on Iran and Nuclear Medicine.Asia Oceania journal of nuclear medicine & biology · 2019Article
- The COVID-19 Pandemic and the Resilience of the Pharmaceutical Supply Chain: Lessons from Past Experiences and Strategies for the Future.Iranian journal of pharmaceutical research : IJPRArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impact of the international sanctions on the Central Bank of Iran in 2013 and also accessibility of medicines in this country have received a lot of media coverage. In this study we used the data collected from a group of pharmacies all located in Tehran to assess the potential effects of the banking sanctions on access to asthma medicines. Data were collected from forty community pharmacies in Tehran, using a standard methodology proposed by the WHO and Health Action International. Data were collected in two stages: first before the sanctions were made against the banking system in the summer of 2012, and second after they were in effect in the summer of 2013, and they were analyzed using univariate analysis techniques. Several imported medicines were already in shortage during 2012. As a result of the sanctions, the availability of both imported and locally manufactured asthma medicines decreased by 19% and 42%, respectively. While before the height of the sanctions 60% of the pharmacies could provide all the essential asthma medicines, this number reduced to 28% after the sanctions (p-value: 0.003). While studies about "access to medicines" in Iran prior to 2011 were indicating appropriate access, our findings suggested that the availability of asthma medicines in community pharmacies was already less than ideal in 2012 and declined dramatically after the latest wave of the sanctions. Our findings show the important effects of the sanctions on availability of asthma medications in community pharmacies.
Indexed as
Identifiers
27980593PMC5149045What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.